ARCHIVES

Iressa Just As Effective As Chemotherapy For Second-Line Therapy, Study Finds

This article is from The Cancer Letter archive.

Vol. 31 No. 11 | November 28, 2008

Download PDF Visit The Full Archive

Related Articles

$2.5 Million NCI Grant To Fund Brachytherapy Improvement

February 27, 2004

BCDDP Follow Up To Cost $1.6 Million annually For Five Years Okayed; Limited To 59,000 Women

November 3, 1978

Von Eschenbach To Leave FDA Jan. 20, Says He Was “In Love” With The Agency.

December 19, 2008

NCI Contract Awards.

February 18, 2000

ACCC T Discuss Personnel, Fund Sources, Clinical Research At Annual Meeting

January 9, 1976

Hood’s ISB Gets $5 Million From Merck, Hires Scientists.

September 1, 2000